Jones Trading Assumes Enliven Therapeutics (ELVN) at Buy
Jones Trading analyst Boris Peaker assumes coverage on Enliven Therapeutics (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
